These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11305068)

  • 1. Prevention of vinorelbine phlebitis with cimetidine. A two-step design study.
    Vassilomanolakis M; Koumakis G; Barbounis V; Orphanos G; Efremidis A
    Support Care Cancer; 2001 Mar; 9(2):108-11. PubMed ID: 11305068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cimetidine attenuates vinorelbine-induced phlebitis in mice by militating E-selectin expression.
    Wang Z; Ma L; Wang X; Cai H; Huang J; Liu J; Hu J; Su D
    Cancer Chemother Pharmacol; 2014 Aug; 74(2):239-47. PubMed ID: 24879290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods of preventing vinorelbine-induced phlebitis: an experimental study in rabbits.
    Kohno E; Murase S; Nishikata M; Okamura N; Matzno S; Kuwahara T; Matsuyama K
    Int J Med Sci; 2008 Jul; 5(4):218-23. PubMed ID: 18695742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of drip infusion versus bolus injection of vinorelbine for the control of local venous toxicity.
    Yoh K; Niho S; Goto K; Ohmatsu H; Kubota K; Kakinuma R; Saijo N; Nishiwaki Y
    Lung Cancer; 2007 Mar; 55(3):337-41. PubMed ID: 17126951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of corticosteroids on phlebitis induced by intravenous infusion of antineoplastic agents in rabbits.
    Kohno E; Murase S; Matsuyama K; Okamura N
    Int J Med Sci; 2009 Aug; 6(5):218-23. PubMed ID: 19680474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High body mass index correlates with increased risk of venous irritation by vinorelbine infusion.
    Yoh K; Niho S; Goto K; Ohmatsu H; Kubota K; Kakinuma R; Nishiwaki Y
    Jpn J Clin Oncol; 2004 Apr; 34(4):206-9. PubMed ID: 15121757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prophylaxis of toxic effects on the peripheral venous system associated with intravenous administration of vinorelbine].
    Cinieri S; Orlando L; Cocorocchio E; Munzone E; Catania C; Brunetti C; Rocca A; Martinelli G; Nolè F
    Clin Ter; 1999; 150(3):225-9. PubMed ID: 10528436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous damage prevention by defibrotide in vinorelbine-treated patients.
    Mare M; Maisano R; Caristi N; Adamo V; Altavilla G; Carboni R; Munaò S; La Torre F
    Support Care Cancer; 2003 Sep; 11(9):593-6. PubMed ID: 12750969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease in the vinorelbine-induced venous irritation by pharmaceutical intervention.
    Yamada T; Egashira N; Watanabe H; Nagata K; Yano T; Nonaka T; Oishi R
    Support Care Cancer; 2012 Jul; 20(7):1549-53. PubMed ID: 21805382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phlebitis after vinorelbine].
    Sauter C; Margulies A; Pestalozzi B
    Schweiz Med Wochenschr; 1998 Feb; 128(9):343. PubMed ID: 9544462
    [No Abstract]   [Full Text] [Related]  

  • 11. Vinorelbine and venous irritation: optimal parenteral administration.
    de Lemos ML
    J Oncol Pharm Pract; 2005 Jun; 11(2):79-81. PubMed ID: 16460608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The incidence of phlebitis in the patients administrated vinorelbine by intravenous bolus injection--a retrospective study].
    Nakayama S; Matsubara N; Sakai T; Aso N
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):633-5. PubMed ID: 11977554
    [No Abstract]   [Full Text] [Related]  

  • 13. Ifosfamide and vinorelbine as first-line chemotherapy for advanced non-small cell lung carcinoma.
    Vallejo C; Romero A; Perez J; Cuevas M; Lacava J; Sabatini C; Dominguez M; Rodriguez R; Barbieri M; Romero Acuña L; Romero Acuña J; Langhi M; Amato S; Salvadori M; Ortiz E; Machiavelli M; Leone B
    Am J Clin Oncol; 1996 Dec; 19(6):584-8. PubMed ID: 8931677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing and managing venous irritation associated with vinorelbine tartrate (Navelbine).
    Rittenberg CN; Gralla RJ; Rehmeyer TA
    Oncol Nurs Forum; 1995 May; 22(4):707-10. PubMed ID: 7675673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of phlebitis caused by vinorelbine chemotherapy in outpatients with breast cancer].
    Yokota Y; Suzuki T; Narahashi T; Takizawa J; Kojima M; Shimada R
    Gan To Kagaku Ryoho; 2008 Sep; 35(9):1525-9. PubMed ID: 18799905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vinorelbine and cisplatin for metastatic breast cancer: a salvage regimen in patients progressing after docetaxel and anthracycline treatment.
    Vassilomanolakis M; Koumakis G; Demiri M; Missitzis J; Barbounis V; Efremidis AP
    Cancer Invest; 2003; 21(4):497-504. PubMed ID: 14533438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I-II vinorelbine (Navelbine) by continuous infusion in patients with metastatic breast cancer: cumulative toxicities limit dose escalation.
    Ibrahim NK; Valero V; Rahman Z; Theriault RL; Walters RS; Buzdar AU; Booser DJ; Holmes FA; Murray JL; Willey J; Bast R; Hortobagyi GN
    Cancer Invest; 2001; 19(5):459-66. PubMed ID: 11458813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defibrotide in the prevention of venous irritation by vinorelbine administration.
    Maisano R; Adamo V; Toscano G; Chiofalo G; Pergolizzi S; Scimone A
    Anticancer Res; 1997; 17(4A):2775-7. PubMed ID: 9252714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bolus injection of vinorelbine reduces incidence of local venous toxicity in patients with non-small cell lung cancer and breast cancer].
    Asako E; Maruyama T; Yamada M; Yoshizaki N; Tsujimura H
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1163-7. PubMed ID: 18633255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel in combination with vinorelbine in pretreated advanced breast cancer patients.
    Michelotti A; Gennari A; Salvadori B; Giannessi PG; Baldini E; Tibaldi C; Da Prato M; Conte PF
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):38-40. PubMed ID: 8893898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.